Why is Pseudomonas aeruginosa a common cause of infection in individuals with cystic fibrosis?

被引：0
作者：
Gross, Jeremy [1 ]
Welch, Martin [1 ]
机构：
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
来源：
FUTURE MICROBIOLOGY | 2013年 / 8卷 / 06期
基金：
英国生物技术与生命科学研究理事会;
关键词：
antibiotic resistance; cystic fibrosis; microbial adaptation; Pseudomonas aeruginosa; BIOFILMS;
D O I：
10.2217/FMB.13.40
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：697 / 699
页数：3
相关论文
共 50 条
  • [31] Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
    Staudinger, Benjamin J.
    Muller, Jocelyn Fraga
    Halldorsson, Skarpheoinn
    Boles, Blaise
    Angermeyer, Angus
    Dao Nguyen
    Rosen, Henry
    Baldursson, Olafur
    Gottfreosson, Magnus
    Guomundsson, Guomundur Hrafn
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (07) : 812 - 824
  • [32] Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis
    Jackson, Lindsay
    Waters, Valerie
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 8 - 16
  • [33] To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
    Reyne, Nicole
    McCarron, Alexandra
    Cmielewski, Patricia
    Parsons, David
    Donnelley, Martin
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [34] Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis
    Keravec, Marlene
    Mounier, Jerome
    Guilloux, Charles-Antoine
    Fangous, Marie-Sarah
    Mondot, Stanislas
    Vallet, Sophie
    Gouriou, Stephanie
    Le Berre, Rozenn
    Rault, Gilles
    Ferec, Claude
    Barbier, Georges
    Lepage, Patricia
    Hery-Arnaud, Genevieve
    BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
  • [35] Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Ehsan, Zarmina
    Wetzel, Jacqueline Denise
    Clancy, John P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 743 - 749
  • [36] Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis
    Elborn, J. Stuart
    Flume, Patrick A.
    Van Devanter, Donald R.
    Procaccianti, Claudio
    FUTURE MICROBIOLOGY, 2021, 16 (14) : 1087 - 1104
  • [37] Bile effects on the Pseudomonas aeruginosa pathogenesis in cystic fibrosis patients with gastroesophageal reflux
    Bayat, Mobina
    Nahand, Javid Sadri
    Farsad-Akhatr, Nader
    Memar, Mohammad Yousef
    HELIYON, 2023, 9 (11)
  • [38] Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa
    van Heeckeren, A
    Walenga, R
    Konstan, MW
    Bonfield, T
    Davis, PB
    Ferkol, T
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) : 2810 - 2815
  • [39] The Costs of Treatment of Early and Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
    Braccini, G.
    Festini, F.
    Boni, V.
    Neri, A. S.
    Galici, V.
    Campana, S.
    Zavataro, L.
    Trevisan, F.
    Braggion, C.
    Taccetti, G.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (02) : 188 - 192
  • [40] How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre
    Kalferstova, L.
    Dedeckova, K. Vilimovska
    Antuskova, M.
    Melter, O.
    Drevinek, P.
    JOURNAL OF HOSPITAL INFECTION, 2016, 92 (01) : 54 - 60
12345